Finasteride Tablets (Greenstone LLC)

Greenstone LLC

Revision date : 2012-04-13

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS08
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

14807-96-6

Name of the chemical

Talc

Concentration

N/A

EC/CAS

13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

N/A

EC/CAS

9005-25-8

Name of the chemical

Starch

Concentration

N/A

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

N/A

EC/CAS

9004-65-3

Name of the chemical

methylhydroxypropylcellulose

Concentration

N/A

EC/CAS

9004-64-2

Name of the chemical

hydroxypropylcellulose

Concentration

N/A

EC/CAS

238-877-9

Name of the chemical

Talc: Hydrated magnesium silicate

Concentration

N/A

EC/CAS

236-675-5

Name of the chemical

Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)

Concentration

N/A

EC/CAS

232-679-6

Name of the chemical

Starch

Concentration

N/A

EC/CAS

209-150-3

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

N/A

EC/CAS

257-098-5

Name of the chemical

Iron Oxide Yellow

Concentration

N/A

General Information

Revision date

2012-04-13

Product name

Finasteride Tablets (Greenstone LLC)

Product Synonyms

None

Chemical name

5-alpha reductase inhibitor

Icons in SDS

Company Information

company name

Greenstone LLC

GHS Information

Signal word

WARNING

Section 2

SECTION 2: Hazards identification

Appearance: Blue tablets

Signal word

WARNING

Hazard statements

Harmful if swallowed. Suspected of damaging the unborn child.

Additional information

Short Term: May be absorbed through the skin and cause systemic effects. Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on developing fetus. Known Clinical Effects: Clinical use of this drug has caused hypersensitivity reactions, skin rash, hives, redness and swelling of the skin (urticaria) impotence, sexual disturbances, and changes in sexual desire (libido). EU Indication of danger: Harmful Toxic to Reproduction: Category 3 EU Risk Phrases: R22 - Harmful if swallowed. R63 - Possible risk of harm to the unborn child. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.